Jan. 21, 2014 9:15 am

UMB BioPark biotech company Noxilizer expands to Europe

Noxilizer CEO Lawrence Bruder, left, with Maryland Governor Martin O'Malley. Photo courtesy of the UMB Elm.

Biotech company Noxilizer, based out of the University of Maryland BioPark, has set up a sales operation in Europe.

The company, which “manufactures sterilization technology for medical devices and equipment,” announced in a press release that its expansion to Europe “is intended to accelerate the global acceptance of nitrogen dioxide sterilization as a powerful, efficient, and cost-saving alternative to traditional sterilization methods.”

Read more at Noxilizer.



Sign-up for regular updates from Baltimore.